immatics biotechnologies ...
(IMTXW)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -96.99M | 37.51M | -93.33M | -229.62M | -32.49M | -32.35M |
| Depreciation & Amortization | 7.23M | 6.97M | 5.26M | 4.42M | 3.86M | 2.18M |
| Stock-Based Compensation | 20.70M | 22.57M | 26.40M | 22.95M | 852.00K | 1.48M |
| Other Working Capital | 84.61M | -7.87M | -483.00K | -1.60M | -1.50M | 5.61M |
| Other Non-Cash Items | 5.65M | -8.70M | 433.00K | 145.87M | 1.24M | -271.00K |
| Deferred Income Tax | n/a | 4.52M | 11.15M | -3.96M | 623.00K | 491.00K |
| Change in Working Capital | 81.63M | 37.26M | -31.70M | -25.28M | 96.88M | 49.16M |
| Operating Cash Flow | 18.23M | 100.13M | -81.78M | -85.61M | 70.97M | 20.68M |
| Capital Expenditures | -30.96M | -6.21M | -5.66M | -7.52M | -2.23M | -507.00K |
| Acquisitions | n/a | -199.91M | 551.00K | 104.00K | 91.00K | 97.01K |
| Purchase of Investments | -415.32M | -216.32M | -11.30M | -82.93M | -77.81M | -13.10M |
| Sales Maturities Of Investments | 414.74M | 12.70M | 24.45M | 74.50M | 74.89M | n/a |
| Other Investing Acitivies | -8.00K | 199.96M | -551.00K | -104.00K | 6.00K | 94.00K |
| Investing Cash Flow | -31.39M | -209.79M | 7.49M | -15.95M | -5.06M | -13.51M |
| Debt Repayment | -3.85M | -2.84M | -2.71M | -2.10M | -1.86M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -2.04M | -7.93M | n/a | -7.94M | n/a | n/a |
| Financial Cash Flow | 84.52M | 123.71M | -2.61M | 207.88M | -1.86M | 23.65M |
| Net Cash Flow | 69.95M | 15.53M | -74.54M | 104.18M | 63.99M | 30.95M |
| Free Cash Flow | -12.73M | 93.92M | -87.44M | -93.13M | 68.73M | 20.18M |